NKNadia Kaouane

Nadia Kaouane

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nadia Kaouane has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Monique Vallée

    Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, Bordeaux, France

    3 shared publications
  • A Desmedt

    1] Pathophysiology of Neuronal Plasticity, Université de Bordeaux, Bordeaux, France [2] INSERM U862, Neurocentre Magendie, Pathophysiology of Declarative Memory, Bordeaux, France

    2 shared publications
  • A Le Roux

    1] INSERM U862, Neurocentre Magendie, Pathophysiology of Addiction, Bordeaux, France [2] Pathophysiology of Neuronal Plasticity, Université de Bordeaux, Bordeaux, France

    2 shared publications
  • F Rougé-Pont

    1] INSERM U862, Neurocentre Magendie, Pathophysiology of Addiction, Bordeaux, France [2] Pathophysiology of Neuronal Plasticity, Université de Bordeaux, Bordeaux, France

    2 shared publications
  • F Tronche

    CNRS UMR7224, UPMC Université Pierre et Marie Curie, Molecular Genetics, Neurophysiology and Behavior, Paris, France

    2 shared publications
  • Jean-Michel Revest

    Univ. Bordeaux, INSERM, Neurocentre Magendie, U1215, F-33000 Bordeaux, France

    2 shared publications

Latest Publications

  • Open Access

    Central amygdala circuit dynamics underlying the benzodiazepine anxiolytic effect

    by Johannes Griessner, Manuel Pasieka, Vincent Böhm, Florian Grössl, Joanna Kaczanowska, Pinelopi Pliota, Dominic Kargl, Barbara Werner, Nadia Kaouane, Sandra Strobelt, et al.

    Benzodiazepines (BZDs) have been a standard treatment for anxiety disorders for decades, but the neuronal circuit interactions mediating their anxiolytic effect remain largely unknown. Here, we find that systemic BZDs modulate central amygdala (CEA) microcircuit activity to gate amygdala output. Combining connectome data with immediate early gene (IEG) activation maps, we identified the CEA as a primary site for diazepam (DZP) anxiolytic action. Deep brain calcium imaging revealed that brain-wide DZP interactions shifted neuronal activity in CEA microcircuits. Chemogenetic silencing showed that PKCδ + /SST − neurons in the lateral CEA (CEAl) are necessary and sufficient to induce the DZP anxiolytic effect. We propose that BZDs block the relay of aversive signals through the CEA, in part by local binding to CEAl SST + /PKCδ − neurons and reshaping intra-CEA circuit dynamics. This work delineates a strategy to identify biomedically relevant circuit interactions of clinical drugs and highlights the critical role for CEA circuitry in the pathophysiology of anxiety.


  • Open Access

    BDNF-TrkB signaling through Erk1/2MAPK phosphorylation mediates the enhancement of fear memory induced by glucocorticoids

    by J-M Revest, A Le Roux, V Roullot-Lacarrière, N Kaouane, M Vallée, F Kasanetz, F Rougé-Pont, F Tronche, A Desmedt, P V Piazza

    Activation of glucocorticoid receptors (GR) by glucocorticoid hormones (GC) enhances contextual fear memories through the activation of the Erk1/2MAPK signaling pathway. However, the molecular mechanism mediating this effect of GC remains unknown. Here we used complementary molecular and behavioral approaches in mice and rats and in genetically modified mice in which the GR was conditionally deleted (GRNesCre). We identified the tPA-BDNF-TrkB signaling pathway as the upstream molecular effectors of GR-mediated phosphorylation of Erk1/2MAPK responsible for the enhancement of contextual fear memory. These findings complete our knowledge of the molecular cascade through which GC enhance contextual fear memory and highlight the role of tPA-BDNF-TrkB-Erk1/2MAPK signaling pathways as one of the core effectors of stress-related effects of GC.


  • Glucocorticoids Can Induce PTSD-Like Memory Impairments in Mice

    by Nadia Kaouane, Yves Porte, Monique Vallée, Laurent Brayda-Bruno, Nicole Mons, Ludovic Calandreau, Aline Marighetto, Pier Vincenzo Piazza, Aline Desmedt

    Remembering Stressful Events: Situations surrounding emotional events are better remembered than others that accompany neutral events. However, in severe pathological states such as posttraumatic stress disorder (PTSD), exposure to threatening situations can also result in memory impairment. In this case, a hypermnesia for a salient trauma-related cue is associated with loss of memory for important aspects of the traumatic event. The memory for the core traumatic event is enhanced, but the capacity to place it in the right place and in response to the right cues is reduced. Kaouane et al. (p. 1510 , published online 23 February) associated a high-intensity threat with the infusion of corticosterone in the hippocampus to induce PTSD-like memory impairments in mice. The animals became unable to identify the threat context as the right predictor of the threat, and they showed a fear response for discrete salient cues normally identified as safe. The neural activation patterns in the amygdala and hippocampal regions of these mice were similar to those observed in human PTSD.


  • Open Access

    The enhancement of stress-related memory by glucocorticoids depends on synapsin-Ia/Ib

    by J-M Revest, N Kaouane, M Mondin, A Le Roux, F Rougé-Pont, M Vallée, J Barik, F Tronche, A Desmedt, P V Piazza

    The activation of glucocorticoid receptors (GR) by glucocorticoids increases stress-related memory through the activation of the MAPK signaling pathway and the downstream transcription factor Egr-1. Here, using converging in vitro and in vivo approaches, respectively, GR-expressing cell lines, culture of hippocampal neurons, and GR genetically modified mice (GRNesCre), we identified synapsin-Ia/Ib as one of the effectors of the glucocorticoid signaling cascade. Stress and glucocorticoid-induced activation of the GR modulate synapsin-Ia/Ib through two complementary mechanisms. First, glucocorticoids driving Egr-1 expression increase the expression of synapsin-Ia/Ib, and second, glucocorticoids driving MAPK activation increase its phosphorylation. Finally, we showed that blocking fucosylation of synapsin-Ia/Ib in the hippocampus inhibits its expression and prevents the glucocorticoid-mediated increase in stress-related memory. In conclusion, our data provide a complete molecular pathway (GR/Egr-1/MAPK/Syn-Ia/Ib) through which stress and glucocorticoids enhance the memory of stress-related events and highlight the function of synapsin-Ia/Ib as molecular effector of the behavioral effects of stress.